GlassScriptPhysician profile
Mark T Boschert
NPI 1558389866
$15,757.66
in general payments reported to CMS, 2019-2025
20 companies · $1,511 in 2025
The $1,511 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,954 · 2020: $493 · 2021: $2,698 · 2022: $3,084 · 2023: $2,674 · 2024: $3,343 · 2025: $1,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,457 · Travel and Lodging: $2,596 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $417 · Education: $59.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,456.76 |
| Travel and Lodging | $2,595.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $416.67 |
| Education | $59.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,110.69 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants, Alloderm |
| Allergan, INC. | $2,972.64 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $2,079.92 | 2019-2022 | |
| Axogen | $1,745.51 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Galderma Laboratories, L.P. | $1,215.72 | 2019-2025 | |
| Sientra, INC. | $1,062.45 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $491.29 | 2021 | |
| Merz North America, INC. | $486.90 | 2019-2023 | Xeomin |
| Mentor Worldwide LLC | $370.45 | 2022-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Rti Surgical, INC | $339.92 | 2022-2025 | |
| Davol INC. | $270.54 | 2022-2023 | Arista Ah Flexitip |
| Amgen INC. | $181.50 | 2019-2020 | |
| Revance Therapeutics, INC. | $139.43 | 2024-2025 | Daxxify |
| Tela Bio, INC. | $131.39 | 2024 | Ovitex 2s |
| Stryker Corporation | $43.22 | 2025 | Dermacell |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $30.06 | 2025 | |
| Biocircuit Technologies INC | $26.69 | 2025 | Nerve Tape |
| Pacira Pharmaceuticals Incorporated | $21.19 | 2025 | Exparel |
| Kci USA, INC. | $19.28 | 2021 | |
| Aclaris Therapeutics, INC. | $18.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Boschert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.